Canada Life’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $10.2M | Sell |
|
|||||
|
2025
Q2 | $9.45M | Sell |
|
|||||
|
2025
Q1 | $9.89M | Sell |
|
|||||
|
2024
Q4 | $12.8M | Sell |
|
|||||
|
2024
Q3 | $11.6M | Buy |
|
|||||
|
2024
Q2 | $12.6M | Buy |
|
|||||
|
2024
Q1 | $11.1M | Sell |
|
|||||
|
2023
Q4 | $11.2M | Sell |
|
|||||
|
2023
Q3 | $10.3M | Sell |
|
|||||
|
2023
Q2 | $9.23M | Sell |
|
|||||
|
2023
Q1 | $10M | Sell |
|
|||||
|
2022
Q4 | $11.9M | Buy |
|
|||||
|
2022
Q3 | $10.3M | Sell |
|
|||||
|
2022
Q2 | $10.3M | Buy |
|
|||||
|
2022
Q1 | $9.67M | Sell |
|
|||||
|
2021
Q4 | $8.94M | Buy |
|
|||||
|
2021
Q3 | $7.34M | Buy |
|
|||||
|
2021
Q2 | $6.62M | Sell |
|
|||||
|
2021
Q1 | $7.15M | Buy |
|
|||||
|
2020
Q4 | $3.4M | Sell |
|
|||||
|
2020
Q3 | $3.99M | Buy |
|
|||||
|
2020
Q2 | $4.37M | Buy |
|
|||||
|
2020
Q1 | $2.79M | Sell |
|
|||||
|
2019
Q4 | $3.59M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $951K | Sell |
|
|||||
|
2019
Q1 | $1.09M | Buy |
|
|||||
|
2018
Q4 | $751K | Buy |
|
|||||
|
2018
Q3 | $1.26M | Hold |
|
|||||
|
2018
Q2 | $1.01M | Hold |
|
|||||
|
2018
Q1 | $852K | Hold |
|
|||||
|
2017
Q4 | $794K | Hold |
|
|||||
|
2017
Q3 | $608K | Hold |
|
|||||
|
2017
Q2 | $471K | Hold |
|
|||||
|
2017
Q1 | $443K | Hold |
|
|||||
|
2016
Q4 | $399K | Hold |
|
|||||
|
2016
Q3 | $519K | Hold |
|
|||||
|
2016
Q2 | $465K | Buy |
|
|||||
|
2016
Q1 | $334K | Hold |
|
|||||
|
2015
Q4 | $478K | Buy |
|
|||||
|
2015
Q3 | $277K | Sell |
|
|||||
|
2015
Q2 | $337K | Hold |
|
|||||
|
2015
Q1 | $281K | Buy |
|
|||||
|
2014
Q4 | $103K | Hold |
|
|||||
|
2014
Q3 | $73K | Hold |
|
|||||
|
2014
Q2 | $69K | Hold |
|
|||||
|
2014
Q1 | $74K | Hold |
|
|||||
|
2013
Q4 | $44K | Buy |
|